SAN JOSE, Calif.,/NEW YORK, March 24 (Reuters) – A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a…
The post UPDATE 1-Gilead ordered to pay Merck $200 mln in hepatitis C drug patent dispute appeared first on NASDAQ.